Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas
CONCLUSIONS: Of all the features evaluated, only the multifocal nature of pancreatic neuroendocrine tumour (PanNET) lesions and a positive family history differentiated between patients with sporadic and MEN-1-related insulinomas. An age of insulinoma diagnosis of less than 30 years may be a strong indicator of an increased risk of MEN-1 syndrome.PMID:37431872 | DOI:10.5603/EP.a2023.0049 (Source: Endokrynologia Polska)
Source: Endokrynologia Polska - July 11, 2023 Category: Endocrinology Authors: Marta Opali ńska Aleksandra Gilis-Januszewska Karolina Morawiec-S ławek Anna Kurzy ńska Anna Sowa-Staszczak Anna Bogus ławska Ewelina Rzepka Alicja Hubalewska-Dydejczyk Source Type: research

Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome
ConclusionsWe found a significantly higher prevalence of angiofibromas and lipomas in F-MEN1 compared with S-MEN1 and in MEN1 mutation-positive compared to MEN1 mutation-negative patients. In patients with one major endocrine manifestation of MEN1, the presence of cutaneous lesions might suggest the diagnosis of MEN1 and a possible indication for genetic screening. (Source: Frontiers in Endocrinology)
Source: Frontiers in Endocrinology - July 7, 2023 Category: Endocrinology Source Type: research

Cancers, Vol. 15, Pages 3494: Relevance of Endoscopic Ultrasound in Endocrinology Today: Multiple Endocrine Neoplasia Type 1, Insulinoma, Primary Aldosteronism & mdash;An Expert & rsquo;s Perspective Based on Three Decades of Scientific and Clinical Experience
Cancers, Vol. 15, Pages 3494: Relevance of Endoscopic Ultrasound in Endocrinology Today: Multiple Endocrine Neoplasia Type 1, Insulinoma, Primary Aldosteronism—An Expert’s Perspective Based on Three Decades of Scientific and Clinical Experience Cancers doi: 10.3390/cancers15133494 Authors: Peter Herbert Kann In endocrinology, endoscopic ultrasound (EUS) may be used to image the adrenals, the endocrine pancreas, and other organs where endocrine neoplasms may occur. During the recent decades, EUS has been established predominantly to assess multiple endocrine neoplasia type 1, to localize insulino...
Source: Cancers - July 4, 2023 Category: Cancer & Oncology Authors: Peter Herbert Kann Tags: Perspective Source Type: research